市场调查报告书
商品编码
1182192
2022-2029 年全球缓释辅料市场规模、研究和预测、按产品、给药途径、技术和地区分析Global Sustained Release Excipients Market Size study & Forecast, by Product by Route of Administration, by Technology and Regional Analysis, 2022-2029 |
2021 年全球缓释辅料市场价值约 11.9 亿美元,预计在 2022-2029 年预测期内以超过 8.22% 的健康增长率增长。
缓释赋形剂是设计用于在特定时间段内缓慢释放药物的剂型,有助于保持一致的药物浓度,同时最大限度地减少副作用。 儿科和老年人对缓释剂型的需求不断增长,缓释赋形剂相对于传统剂型的优势越来越大,这些都成为全球市场需求的主要催化剂。
口服给药技术的发展一直强调提高药物治疗能力以及生物利用度和患者依从性。
例如,2021 年 9 月在美国国家生物技术信息中心 (NCBI) 发表的一篇论文描述了胃滞留给药技术在上消化道维持剂型的潜在用途。因此,这些具有缓释方法的技术将通过减少给药频率提供更好的患者依从性和治疗效果,从而加速全球市场的市场需求。 此外,对抗生素耐药性的日益关注和由于配方特性而增加的可接受性也是未来几年增加市场机会的因素。 然而,由于剂量倾销和对更高剂量 API 的需求不断增长,潜在的药物毒性与潜在的药物毒性有关,从而限制了整个 2022-2029 年预测期内的市场增长。
研究全球控释辅料市场的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 在北美,专利到期、仿製药继续进入以及研发投资增加带来了盈利优势。 另一方面,预计亚太地区在预测期内将显着增长。 未来将加速市场增长的因素包括各种传染病的增加、对高效治疗药物的需求不断增长以及新生产设施的建立。
本研究的目的是阐明近年来各个细分市场和国家/地区的市场规模,并预测未来几年的市场规模。 该报告旨在包括被调查国家工业的定性和定量方面。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。 此外,它还包含供利益相关者投资的微观市场潜在机会,以及对主要参与者的竞争格局和产品供应的深入分析。
Global Sustained Release Excipients Market is valued at approximately USD 1.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.22% over the forecast period 2022-2029. Sustained release excipients are a dosage form that is designed to release a drug slowly during a specific period to help in maintaining a constant drug concentration with minimum side effects. The growing need for pediatric and geriatric sustained release dosage forms and rising benefits of sustained release excipients compared to conventional dosage forms are acting as a major catalyzing factor for the market demand around the world.
The rising emphasis on the development of oral drug delivery technologies is because of improving drug therapeutic competence, along with bioavailability and patient compliance.
For instance, an article published in the National Center for Biotechnology Information (NCBI) on September 2021 stated the potential use of gastro retentive drug delivery techniques that maintain dose forms in the upper gastrointestinal tract. Thus, these technologies with sustained-release approaches offer better patient compliance and therapeutic effectiveness by decreasing dosing frequency, which, in turn, fuels the market demand in the global market. Furthermore, the growing focus on antibiotic resistance, as well as increasing acceptance owing to the nature of dosage forms are further factors that are leveraging the market opportunities in the forthcoming years. However, the chances of drug toxicity are associated due to dose dumping and the growing need for the high dose of API is restricting the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Sustained Release Excipients Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the patent expirations and successive entry of generics, along with the growing investment in R&D activities. Whereas, the Asia Pacific is expected to grow significantly during the forecast period. Factors such as the increasing prevalence of various infectious diseases, the growing need for highly effective therapeutics, as well as rising establishment of production facilities, are burgeoning the market growth in the forecasting years.
Major market players included in this report are:
BASF SE
International Flavors & Fragrances, Inc.
Ashland Global
Evonik Industries
Croda International Plc
Gattefosse
Merck KGaA
Pfizer, Inc.
Sun Pharmaceutical Industries Ltd.
Mayne Pharma Group Limited
Recent Developments in the Market:
Global Sustained Release Excipients Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Route of Administration, Technology, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Gelatin
Polymers
Minerals
Sugars
Others
By Route of Administration:
Oral
Intramuscular
Subcutaneous
Transdermal
Intravenous
Others
By Technology:
Targeted Delivery
Microencapsulation
Wurster Technique
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable